Qiming U.S. Ventures Management
Latest statistics and disclosures from Qiming U.S. Ventures Management's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by Qiming U.S. Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Qiming U.S. Ventures Management
Qiming U.S. Ventures Management holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tourmaline Bio (TRML) | 37.1 | $19M | 742k | 25.71 |
|
|
| Jasper Therapeutics Com New (JSPR) | 34.0 | $18M | 929k | 18.81 |
|
|
| Korro Bio (KRRO) | 23.9 | $12M | 368k | 33.42 |
|
|
| Hillevax (HLVX) | 1.9 | $984k | 559k | 1.76 |
|
|
| Ventyx Biosciences (VTYX) | 1.7 | $899k | 412k | 2.18 |
|
|
| Kezar Life Sciences (KZR) | 1.2 | $638k | 829k | 0.77 |
|
Past Filings by Qiming U.S. Ventures Management
SEC 13F filings are viewable for Qiming U.S. Ventures Management going back to 2021
- Qiming U.S. Ventures Management 2024 Q3 filed Nov. 7, 2024
- Qiming U.S. Ventures Management 2024 Q2 filed Aug. 13, 2024
- Qiming U.S. Ventures Management 2024 Q1 filed May 14, 2024
- Qiming U.S. Ventures Management 2023 Q4 filed Feb. 14, 2024
- Qiming U.S. Ventures Management 2023 Q3 filed Nov. 9, 2023
- Qiming U.S. Ventures Management 2023 Q2 filed July 24, 2023
- Qiming U.S. Ventures Management 2023 Q1 filed April 25, 2023
- Qiming U.S. Ventures Management 2022 Q4 filed Jan. 24, 2023
- Qiming U.S. Ventures Management 2022 Q3 filed Nov. 8, 2022
- Qiming U.S. Ventures Management 2022 Q2 filed July 22, 2022
- Qiming U.S. Ventures Management 2022 Q1 filed May 16, 2022
- Qiming U.S. Ventures Management 2021 Q4 filed Feb. 14, 2022